Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 19,037 shares at $14.23 ($271K) on 2026-04-27, disclosed to the SEC on 2026-04-29.
Scheduled sale ($271k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |